- 질문내용 -
I'm a member of a gym government research paper LONDON, Sept 20 (Reuters) - An experimental drug forDuchenne muscular dystrophy (DMD) from GlaxoSmithKline and Prosensa failed to meet its goal in a late-stageclinical trial, sending shares in Prosensa tumbling 70 percent.
|
|
